Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. [electronic resource]
Producer: 20140527Description: 418-27 p. digitalISSN:- 2326-5205
- Animals
- Biomarkers -- metabolism
- Bleomycin -- adverse effects
- Chemokine CCL2 -- metabolism
- Cohort Studies
- Comorbidity
- Disease Models, Animal
- Fibroblasts -- drug effects
- Follow-Up Studies
- Growth Differentiation Factor 15 -- deficiency
- Humans
- In Vitro Techniques
- Interleukin-6 -- metabolism
- Longitudinal Studies
- Lung -- drug effects
- Mice
- Mice, Knockout
- Prospective Studies
- Pulmonary Fibrosis -- epidemiology
- Scleroderma, Systemic -- chemically induced
- Skin Diseases -- epidemiology
- Stromal Cells -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.